Initially, its role as a pro-inflammatory cytokine serves to eliminate tumor antigens; however, as the cancer progresses, the polarization of naïve CD4+ T-helper cells towards pathogenic Th17 lineage releases IL-17 and also IL-6 cytokines that are important to advance tumor stage and development. Here, IL17A is linked to neoplasm.